Company news
HCW Biologics Inc. news in 2023
HCW Biologics Inc.'s news releases, calls and decks from 2023, newest first.
HCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business Highlights
November 13, 2023
Investigator Sponsor of HCW Biologics’ Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting
November 7, 2023
HCW Biologics Participating at H.C. Wainwright 25th Annual Global Investment Conference in New York on September 11 – 13, 2023
September 5, 2023
HCW Biologics Reports Second Quarter 2023 Financial Results and Recent Business Highlights
August 10, 2023
HCW Biologics is Granted Third Fundamental Patent: U.S. Patent for Methods of Treating Age-Related Disorders
June 13, 2023
HCW Biologics Reports First Quarter 2023 Financial Results And Recent Business Highlights
May 8, 2023
HCW Biologics Secures $26.25 Million Non-Dilutive Financing With Asset-Backed Development Loan
April 26, 2023
HCW Biologics Poster Presentation at AACR Annual Meeting 2023
April 12, 2023
A Novel Immunotherapeutic Approach to Treating Aging-Associated Diseases
April 2, 2023
HCW Biologics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Business Highlights
March 27, 2023